Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 23:7:1571-1577.
doi: 10.1016/j.toxrep.2020.11.008. eCollection 2020.

Resveratrol, curcumin and gallic acid attenuate glyoxal-induced damage to rat renal cells

Affiliations

Resveratrol, curcumin and gallic acid attenuate glyoxal-induced damage to rat renal cells

Mahmoud Hashemzaei et al. Toxicol Rep. .

Abstract

Glyoxal (GO), a by-product of glucose auto-oxidation, is involved in the glycation of proteins/ lipids and formation of advanced glycation (AGE) and lipoxidation (ALE) end products. AGE/ALE were shown to contribute to diabetic complications development/progression such as nephropathy. Diabetic nephropathy progression has an oxidative nature. Given the antioxidant effects of polyphenols, potential protective effects of resveratrol, curcumin and gallic acid, in rat renal cells treated with GO, were evaluated in the present work. According to our results, incubation of GO with the cells reduced their viability and led to membrane lysis, reactive oxygen species (ROS) formation, lipid peroxidation, mitochondrial membrane potential collapse, and lysosomal membrane leakage. These findings were prevented by pre-treatment with resveratrol, curcumin and gallic acid. Mitochondrial and lysosomal toxic interactions appear to worsen oxidative stress/cytotoxicity produced by GO. Resveratrol, curcumin and gallic acid inhibited ROS formation and attenuated GO-induced renal cell death.

Keywords: Animal; Curcumin; Diabetes; Gallic acid; Glyoxal; Kidney; Natural products; Polyphenols.

PubMed Disclaimer

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Protective effects of various treatments against lipid peroxidation induced by GO in rat renal cells. Data are expressed as mean ± SD of three separate experiments (n = 3). aSignificantly different from the control renal cells (P < 0.05). b Significantly different from the GO-treated renal cells (P < 0.05). GO: glyoxal; DMSO: dimethyl sulfoxide and SD: standard deviation.

Similar articles

Cited by

References

    1. Brownlee M., Vlassara H., Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 1984;101(4):527–537. - PubMed
    1. Thornalley P.J. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell. Mol. Biol. (Noisy-le-grand) 1998;44(7):1013–1023. - PubMed
    1. Vitek M.P. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. 1994;91(11):4766–4770. - PMC - PubMed
    1. Vanessa Fiorentino T. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr. Pharm. Des. 2013;19(32):5695–5703. - PubMed
    1. Bech P., Moses R., Gomis R. The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy-naïve Type 2 diabetes: a placebo-controlled, multicentre study. Qual. Life Res. 2003;12(4):413–425. - PubMed

LinkOut - more resources